Aspartate 496 from the subsite S2 drives specificity of human dipeptidyl peptidase III

Biological Chemistry
|January 13, 2015
PubMed

Insights

Human dipeptidyl peptidase III (hDPP III) enzyme specificity was investigated. Site-directed mutagenesis identified Asp496 as crucial for hDPP III

Area of Science:

  • Biochemistry
  • Enzymology
  • Proteolysis

Background:

  • Human dipeptidyl peptidase III (hDPP III) is a metallopeptidase involved in protein catabolism and oxidative stress.
  • Understanding hDPP III substrate specificity is key to elucidating its biological roles.

Purpose of the Study:

  • To investigate the structural basis for hDPP III's preference for diarginyl arylamide substrates.
  • To identify key residues determining substrate specificity using site-directed mutagenesis.

Main Methods:

  • Site-directed mutagenesis was employed to alter the S2 subsite of hDPP III.
  • Kinetic studies were performed to analyze enzyme-substrate interactions.
  • Binding assays were conducted using peptides and tynorphin.

Main Results:

  • The D496G mutant exhibited significantly reduced substrate selectivity, indicated by an increased Km value.
  • The D496G mutant showed decreased binding affinity for N-terminal arginine peptides and tynorphin.
  • The S504G mutation did not significantly impact substrate binding or selectivity.

Conclusions:

  • Asp496 is identified as a critical determinant of human dipeptidyl peptidase III substrate specificity.
  • The S2 subsite plays a crucial role in the enzyme's preference for specific substrates, particularly those with N-terminal arginine.

Related Concept Videos

Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
7.0K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
14.7K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.4K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
6.0K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
3.2K